Gross profit of Sobi 2009-2022

Published by
Matej Mikulic,
Apr 6, 2023
Gross profits of Swedish biopharmaceutical company Sobi increased every year since 2011. The increase was especially significant during the latest years of the observed period. In 2022, the gross profit of Sobi was more than 14 billion Swedish kronor for the first time. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases.

Gross profit of Sobi from 2009 to 2022 (in million SEK)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2023

Region

Sweden

Survey time period

2009 to 2022

Supplementary notes

Some figures has been taken from previous publications.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

9

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the UKGlobal pharmaceutical industryPharmaceutical industry in the U.S.AstraZenecaNational Health Service (NHS) UK
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu